Clinical trajectories and biomarkers for weight variability in early Parkinson’s disease

[1]  E. Simonsick,et al.  Changes in Body Composition Before and After Parkinson's Disease Diagnosis , 2021, Movement disorders : official journal of the Movement Disorder Society.

[2]  K. Chaudhuri,et al.  Serum Uric Acid Levels and Non-Motor Symptoms in Parkinson's Disease. , 2020, Journal of Parkinson's disease.

[3]  Myung Jun Lee,et al.  Prediction of future weight change with dopamine transporter in patients with Parkinson’s disease , 2019, Journal of Neural Transmission.

[4]  Norbert Schuff,et al.  The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort , 2018, Annals of clinical and translational neurology.

[5]  Myung Jun Lee,et al.  Weight loss is associated with rapid striatal dopaminergic degeneration in Parkinson's disease. , 2018, Parkinsonism & related disorders.

[6]  K Ray Chaudhuri,et al.  Non‐motor Parkinson disease: new concepts and personalised management , 2018, The Medical journal of Australia.

[7]  Kai Ma,et al.  Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects , 2018, Front. Aging Neurosci..

[8]  C. Counsell,et al.  Early weight loss in parkinsonism predicts poor outcomes , 2017, Neurology.

[9]  Amanda Jiménez,et al.  Weight loss in the healthy elderly might be a non-cognitive sign of preclinical Alzheimer's disease , 2017, Oncotarget.

[10]  A. Dagher,et al.  Clinical criteria for subtyping Parkinson’s disease: biomarkers and longitudinal progression , 2017, Brain : a journal of neurology.

[11]  H. Matsuno,et al.  Body weight and dysautonomia in early Parkinson's disease , 2017, Acta neurologica Scandinavica.

[12]  D. Waters,et al.  Body‐Weight Fluctuations and Outcomes in Coronary Disease , 2017, The New England journal of medicine.

[13]  Connie Marras,et al.  Nonmotor features of Parkinson's disease subtypes , 2016, Movement disorders : official journal of the Movement Disorder Society.

[14]  Z. Mari,et al.  Association Between Change in Body Mass Index, Unified Parkinson's Disease Rating Scale Scores, and Survival Among Persons With Parkinson Disease: Secondary Analysis of Longitudinal Data From NINDS Exploratory Trials in Parkinson Disease Long-term Study 1. , 2016, JAMA neurology.

[15]  X. Cen,et al.  Uric Acid Produces an Inflammatory Response through Activation of NF-κB in the Hypothalamus: Implications for the Pathogenesis of Metabolic Disorders , 2015, Scientific Reports.

[16]  Nikolaus R. McFarland,et al.  Weight Loss and Impact on Quality of Life in Parkinson’s Disease , 2015, PloS one.

[17]  S. Cho,et al.  Asymmetry of Dopamine D2/3 Receptor Availability in Dorsal Putamen and Body Mass Index in Non-obese Healthy Males , 2015, Experimental neurobiology.

[18]  M. Vassallo,et al.  Prognostic significance of weight changes in Parkinson's disease: the Park-weight phenotype. , 2014, Neurodegenerative disease management.

[19]  P. Krack,et al.  Mechanisms of Body Weight Fluctuations in Parkinson’s Disease , 2014, Front. Neurol..

[20]  Lilah M. Besser,et al.  Body Mass Index, Weight Change, and Clinical Progression in Mild Cognitive Impairment and Alzheimer Disease , 2014, Alzheimer disease and associated disorders.

[21]  C. Garrett,et al.  Locus Coeruleus Is Involved in Weight Loss in a Rat Model of Parkinson's Disease: An Effect Reversed by Deep Brain Stimulation , 2013, Brain Stimulation.

[22]  J. Sharma,et al.  Olfaction, dyskinesia and profile of weight change in Parkinson's disease: identifying neurodegenerative phenotypes. , 2012, Parkinsonism & related disorders.

[23]  E. Oh,et al.  Relationship between changes of body mass index (BMI) and cognitive decline in Parkinson's disease (PD). , 2012, Archives of gerontology and geriatrics.

[24]  A. Singleton,et al.  The Parkinson Progression Marker Initiative (PPMI) , 2011, Progress in Neurobiology.

[25]  R. Honea,et al.  Alzheimer disease biomarkers are associated with body mass index , 2011, Neurology.

[26]  Brit Mollenhauer,et al.  α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study , 2011, The Lancet Neurology.

[27]  Hyon K. Choi,et al.  The serum urate-lowering impact of weight loss among men with a high cardiovascular risk profile: the Multiple Risk Factor Intervention Trial. , 2010, Rheumatology.

[28]  J. Trojanowski,et al.  CSF amyloid β 1-42 predicts cognitive decline in Parkinson disease , 2010, Neurology.

[29]  A. Lang,et al.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. , 2010, Archives of neurology.

[30]  A. Zapf,et al.  Dopaminergic treatment is associated with decreased body weight in patients with Parkinson’s disease and dyskinesias , 2009, European journal of neurology.

[31]  Hyon K. Choi,et al.  Diet, urate, and Parkinson's disease risk in men. , 2008, American journal of epidemiology.

[32]  B. Winblad,et al.  Late‐Life Body Mass Index and Dementia Incidence: Nine‐Year Follow‐Up Data from the Kungsholmen Project , 2008, Journal of the American Geriatrics Society.

[33]  R. Paffenbarger,et al.  Body mass index and risk of Parkinson's disease: a prospective cohort study. , 2007, American journal of epidemiology.

[34]  O. Kano,et al.  BODY MASS INDEX AND THE RISK OF PARKINSON DISEASE , 2007, Neurology.

[35]  G Hu,et al.  Body mass index and the risk of Parkinson disease , 2006, Neurology.

[36]  M. W. Schwartz,et al.  Central nervous system control of food intake and body weight , 2006, Nature.

[37]  M. Unosson,et al.  Factors of importance for weight loss in elderly patients with Parkinson's disease , 2004, Acta neurologica Scandinavica.

[38]  A. Benabid,et al.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease. , 2003, The New England journal of medicine.

[39]  Miguel A Hernán,et al.  Weight loss in Parkinson's disease , 2003, Annals of neurology.

[40]  M. Canesi,et al.  Is underweightness still a major problem in Parkinson's disease patients? , 2003, European Journal of Clinical Nutrition.

[41]  N. Volkow,et al.  “Nonhedonic” food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect , 2002, Synapse.

[42]  J. Jankovic,et al.  Weight gain following unilateral pallidotomy in Parkinson's disease , 2000, Acta neurologica Scandinavica.

[43]  D. Michalek,et al.  Weight change and body composition in patients with Parkinson's disease. , 1995, Journal of the American Dietetic Association.

[44]  A. Tomkins,et al.  Diet, body size and micronutrient status in Parkinson's disease. , 1992, European journal of clinical nutrition.

[45]  O. Rascol,et al.  Parkinson's disease and weight loss: A study with anthropometric and nutritional assessment , 1992, Clinical Autonomic Research.

[46]  J. Jankovic,et al.  Low Body Weight in Parkinson's Disease , 1992, Southern medical journal.

[47]  D. Spodick.  Multiple risk factor intervention trial. , 1985, The American journal of cardiology.

[48]  K Ray Chaudhuri,et al.  The Nonmotor Features of Parkinson's Disease. , 2017, International review of neurobiology.

[49]  K. Chaudhuri,et al.  Non motor subtypes and Parkinson's disease. , 2016, Parkinsonism & related disorders.

[50]  K. Chaudhuri,et al.  Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect. , 2011, Journal of Parkinson's disease.

[51]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[52]  A. Lang,et al.  A Cross-Sectional Study of 3090 Patients , 2010 .

[53]  L. Liaudet,et al.  Nitric oxide and peroxynitrite in health and disease. , 2007, Physiological reviews.

[54]  J. Saczynski,et al.  The Honolulu-Asia Aging Study , 2007 .

[55]  R. Stewart,et al.  A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study. , 2005, Archives of neurology.